{
    "eid": "2-s2.0-84996565533",
    "title": "Treatment outcomes and validation of the stopping rule for response to peginterferon in chronic hepatitis B: A Thai nationwide cohort study",
    "cover-date": "2016-11-01",
    "subject-areas": [
        {
            "$": "Hepatology",
            "@code": "2721"
        },
        {
            "$": "Gastroenterology",
            "@code": "2715"
        }
    ],
    "keywords": [
        "antiviral therapy",
        "chronic hepatitis B",
        "peginterferon",
        "quantitative HBsAg",
        "stopping rule"
    ],
    "authors": [
        "Phunchai Charatcharoenwitthaya"
    ],
    "citedby-count": 8,
    "ref-count": 23,
    "ref-list": [
        "Guidelines for the Prevention, Care and Treatment of Persons with Chronic Hepatitis B Infection",
        "Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B",
        "Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: A randomised trial",
        "A randomized, controlled trial of combination therapy for chronic hepatitis B: Comparing pegylated interferon-\u03b12b and lamivudine with lamivudine alone",
        "Peginterferon Alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B",
        "Sustained HBeAg and HBsAg Loss After Long-term Follow-up of HBeAg-Positive Patients Treated With Peginterferon \u03b1-2b",
        "Sustained Response of Hepatitis B e Antigen-Negative Patients 3 Years After Treatment with Peginterferon Alfa-2a",
        "A comparison of two assays for quantification of Hepatitis B surface Antigen in patients with chronic hepatitis B",
        "EASL clinical practice guidelines: Management of chronic hepatitis B virus infection",
        "Chronic hepatitis B: Update 2009",
        "Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2012 update",
        "Prediction of Sustained Response to Peginterferon Alfa-2b for Hepatitis B e Antigen\u2013Positive Chronic Hepatitis B Using On-Treatment Hepatitis B Surface Antigen Decline",
        "Hepatitis B virus genotype B results in better immediate, late and sustained responses to peginterferon-alfa in hepatitis-B-e-antigen-positive patients",
        "Hepatitis B surface antigen: Association with sustained response to peginterferon alfa-2a in hepatitis B e antigen-positive patients",
        "Validation of a stopping rule at week 12 using HBsAg and HBV DNA for HBeAg-negative patients treated with peginterferon alfa-2a",
        "Hepatitis B surface antigen levels: Association with 5-year response to peginterferon alfa-2a in hepatitis B e-antigen-negative patients",
        "Long-Term Follow-up of Alpha-Interferon Treatment of Patients with Chronic Hepatitis B",
        "Hepatitis B genotypes and the response to interferon therapy",
        "Genotype B and younger patient age associated with better response to low-dose therapy: A trial with pegylated/nonpegylated interferon-\u03b1-2b for hepatitis B e antigen-positive patients with chronic hepatitis B in China",
        "Sustained response to peginterferon alfa-2a (40 kD) with or without lamivudine in Asian patients with HBeAg-positive and HBeAg-negative chronic hepatitis B",
        "Predicting response to peginterferon \u03b1-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis B",
        "Response to peginterferon alfa-2a (40KD) in HBeAg-negative CHB: On-treatment kinetics of HBsAg serum levels vary by HBV genotype",
        "Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "affilname": "Siriraj Hospital",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Chiang Mai",
            "affilname": "Faculty of Medicine, Chiang Mai University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Khon Kaen",
            "affilname": "Faculty of Medicine, Khon Kaen University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Police General Hospital",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": null,
            "affilname": "Bhumibol Adulyadej Hospital",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Pitsanulok",
            "affilname": "Naresuan University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Vajira Hospital",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Pathum Thani",
            "affilname": "Faculty of Medicine, Thammasat University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Phisanulok",
            "affilname": "Buddhachinaraj Hospital",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Phramongkutklao College of Medicine",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Hatyai",
            "affilname": "Prince of Songkla University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Rajavithi Hospital",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}